Invesaro

Stocks Comparison

Labcorp vs Natera: revenue, profit, margins and growth compared

Labcorp brought in $14B of revenue in fiscal 2025, Natera $2.3B in fiscal 2025. Revenue changed by +7.2% at Labcorp and +35.9% at Natera on the year before, so Natera grew faster. Labcorp kept 6.3% of its revenue as net profit, Natera -9.0%. Free cash flow was $1.2B at Labcorp and $109.1M at Natera.

Side by side, latest fiscal year

LHNTRA
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$14B$2.3B
Revenue growth+7.2%+35.9%
Net income$876.5M-$208.2M
Net margin6.3%-9.0%
Free cash flow$1.2B$109.1M
Free cash flow margin8.6%4.7%
Earnings per share (diluted)$10.46-$1.52
Cash$532.3M$1.1B
Debt$5.6Bn/a
Price to earnings29.6n/a
Market value$25.1B$59.5B
Dividend yield0.93%n/a
Rank by revenue in sector#35 of 523 · Health care#101 of 523 · Health care

Over the years

Revenue
LH FY2018: $11.3BLH FY2019: $11.6BLH FY2020: $14BLH FY2021: $13.1BLH FY2021: $11.9BLH FY2023: $12.2BLH FY2024: $13BLH FY2025: $14BNTRA FY2018: $257.7MNTRA FY2019: $302.3MNTRA FY2020: $391MNTRA FY2021: $625.5MNTRA FY2022: $820.2MNTRA FY2023: $1.1BNTRA FY2024: $1.7BNTRA FY2025: $2.3BFY18FY19FY20FY21FY22FY23FY24FY25
LH $14BNTRA $2.3B
Net income
LH FY2018: $883.7MLH FY2019: $823.8MLH FY2020: $1.6BLH FY2021: $2.4BLH FY2021: $1.3BLH FY2023: $418MLH FY2024: $746MLH FY2025: $876.5MNTRA FY2018: -$128.2MNTRA FY2019: -$124.8MNTRA FY2020: -$229.7MNTRA FY2021: -$471.7MNTRA FY2022: -$547.8MNTRA FY2023: -$434.8MNTRA FY2024: -$190.4MNTRA FY2025: -$208.2MFY18FY19FY20FY21FY22FY23FY24FY25
LH $876.5MNTRA -$208.2M
Net margin
LH FY2018: 7.8%LH FY2019: 7.1%LH FY2020: 11.1%LH FY2021: 18.1%LH FY2021: 10.8%LH FY2023: 3.4%LH FY2024: 5.7%LH FY2025: 6.3%NTRA FY2018: -49.7%NTRA FY2019: -41.3%NTRA FY2020: -58.8%NTRA FY2021: -75.4%NTRA FY2022: -66.8%NTRA FY2023: -40.2%NTRA FY2024: -11.2%NTRA FY2025: -9.0%FY18FY19FY20FY21FY22FY23FY24FY25
LH 6.3%NTRA -9.0%
Revenue growth
LH FY2019: +2.0%LH FY2020: +21.0%LH FY2021: -6.0%LH FY2021: -9.7%LH FY2023: +2.5%LH FY2024: +7.0%LH FY2025: +7.2%NTRA FY2019: +17.3%NTRA FY2020: +29.3%NTRA FY2021: +60.0%NTRA FY2022: +31.1%NTRA FY2023: +32.0%NTRA FY2024: +56.7%NTRA FY2025: +35.9%FY19FY20FY21FY22FY23FY24FY25
LH +7.2%NTRA +35.9%
Free cash flow
LH FY2018: $925.6MLH FY2019: $1BLH FY2020: $1.8BLH FY2021: $2.7BLH FY2021: $1.5BLH FY2023: $874.1MLH FY2024: $1.1BLH FY2025: $1.2BNTRA FY2018: -$74.5MNTRA FY2019: -$68.4MNTRA FY2020: -$202.1MNTRA FY2021: -$376.3MNTRA FY2022: -$479.2MNTRA FY2023: -$286.2MNTRA FY2024: $69.2MNTRA FY2025: $109.1MFY18FY19FY20FY21FY22FY23FY24FY25
LH $1.2BNTRA $109.1M

Fiscal years as each company reports them; the two may end in different months.

Questions about Labcorp and Natera

Which is bigger by revenue, Labcorp or Natera?

Labcorp is bigger by revenue: $14B in fiscal 2025, against $2.3B for Natera in fiscal 2025.

Which keeps more of its revenue as profit, Labcorp or Natera?

Labcorp had a net margin of 6.3% in fiscal 2025; Natera had -9.0% in fiscal 2025.

Which grew revenue faster, Labcorp or Natera?

In their latest fiscal years revenue changed by +7.2% at Labcorp and +35.9% at Natera.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies